Kiora Pharmaceuticals Inc (KPRX)
0.493
0.00 (0.00%)
USD |
NASDAQ |
May 31, 16:00
0.51
+0.02
(+3.45%)
After-Hours: 20:00
Kiora Pharmaceuticals Enterprise Value: -18.33M for May 31, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 31, 2024 | -18.33M |
| May 30, 2024 | -18.25M |
| May 29, 2024 | -17.37M |
| May 28, 2024 | -17.27M |
| May 24, 2024 | -16.94M |
| May 23, 2024 | -17.29M |
| May 22, 2024 | -17.10M |
| May 21, 2024 | -16.60M |
| May 20, 2024 | -16.19M |
| May 17, 2024 | -16.31M |
| May 16, 2024 | -16.01M |
| May 15, 2024 | -17.75M |
| May 14, 2024 | -18.15M |
| May 13, 2024 | -17.89M |
| May 10, 2024 | -18.51M |
| May 09, 2024 | -18.53M |
| May 08, 2024 | -18.44M |
| May 07, 2024 | -18.12M |
| May 06, 2024 | -17.60M |
| May 03, 2024 | -17.80M |
| May 02, 2024 | -17.03M |
| May 01, 2024 | -16.97M |
| April 30, 2024 | -18.08M |
| April 29, 2024 | -18.62M |
| April 26, 2024 | -18.94M |
| Date | Value |
|---|---|
| April 25, 2024 | -18.67M |
| April 24, 2024 | -18.00M |
| April 23, 2024 | -16.06M |
| April 22, 2024 | -18.54M |
| April 19, 2024 | -18.40M |
| April 18, 2024 | -17.89M |
| April 17, 2024 | -17.99M |
| April 16, 2024 | -16.84M |
| April 15, 2024 | -16.57M |
| April 12, 2024 | -16.18M |
| April 11, 2024 | -15.44M |
| April 10, 2024 | -15.66M |
| April 09, 2024 | -16.32M |
| April 08, 2024 | -15.72M |
| April 05, 2024 | -15.58M |
| April 04, 2024 | -16.02M |
| April 03, 2024 | -15.73M |
| April 02, 2024 | -15.84M |
| April 01, 2024 | -15.52M |
| March 31, 2024 | -12.74M |
| March 28, 2024 | 16.08M |
| March 27, 2024 | 13.75M |
| March 26, 2024 | 13.56M |
| March 25, 2024 | 12.80M |
| March 22, 2024 | 13.30M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-18.94M
Minimum
Apr 26 2024
53.74M
Maximum
Feb 10 2021
9.629M
Average
5.796M
Median
Enterprise Value Benchmarks
| Precision Optics Corp Inc | 40.80M |
| Perspective Therapeutics Inc | 680.29M |
| Electromed Inc | 114.83M |
| Xtant Medical Holdings Inc | 116.30M |
| Asensus Surgical Inc | 52.33M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 13.45M |
| Revenue (Quarterly) | 16.00M |
| Total Expenses (Quarterly) | 2.790M |
| EPS Diluted (Quarterly) | 0.38 |
| Profit Margin (Quarterly) | 84.08% |
| Earnings Yield | -323.4% |
| Operating Earnings Yield | 95.10% |
| Normalized Earnings Yield | -212.98 |